Search for: "OXLEY v. STATE" Results 601 - 620 of 659
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
7 Oct 2008, 11:03 am
The court held that the challenged arbitration process established by the arbitration agreement provided Guyden with an adequate opportunity to enforce her statutory rights.This ruling is consistent with the holding of New York's Court of Appeals in Antinore v State [40 NY2d 6]. [read post]
2 Oct 2008, 7:43 pm
Strine notes that Unocal’s board met for eight or nine hours to consider Pickens’ offer — a response to Smith v. [read post]
29 May 2008, 2:47 pm
And to read "Certified Foreign Language Translation and the Sarbanes-Oxley Act of 2002", click here. [read post]
28 May 2008, 5:40 pm
And to read "Certified Foreign Language Translation and the Sarbanes-Oxley Act of 2002", click here. [read post]
23 May 2008, 1:03 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
15 May 2008, 10:20 pm
Stretching Sarbanes-Oxley Beyond Corporate Fraud Keith Bishop notes: The 11th Circuit recently rendered an interesting decision in US v. [read post]
15 Apr 2008, 9:01 am
Pileggi of the Delaware Corporate and Commercial Litigation Blog highlights the District of Delaware's decision in Miller v. [read post]
10 Apr 2008, 10:38 am
9:00 a.m. sesstion:  Culture, Tradition and Language in Cross-Border Negotiations and International Conflict presented by Professor John Barkai, University of Hawaii; Andrew Aglionby, Baker & McKenzie; and, Michael Zacharia, Former Exec. [read post]
14 Mar 2008, 5:15 am
  As the New Jersey Supreme Court stated more than 25 years ago in Francis v. [read post]
7 Mar 2008, 2:00 am
: (IPBiz), US: Proposals for the approval of generic biologics under consideration: (Pharmacapsules@Gowlings), US: A paradigm shift in obviousness for pharma, biotech: (IP Law360), US: USPTO’s Bruce Kisliuk addresses ACI Pharma/biotech patent claim drafting and prosecution conference: (Patent Docs), US: New bill to provide biotech companies Sarbanes-Oxley relief: (California Biotech Law Blog), US: Biotech and pharma companies spent millions on lobbying in 2007:… [read post]
15 Feb 2008, 5:15 am
Indeed, the failure of that revolution may, in part, be responsible for some of the federal intervention into state corporate law wrought by the Sarbanes Oxley Act.The old "conventional wisdom" had been that, under the 1963 Delaware Supreme Court decision in Graham v. [read post]